PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancerLi‐Xu Yan, Jie Chen, Yan‐Hui Liu et al.|International Journal of Oncology|2015Cited by 131
Deep learning with biopsy whole slide images for pretreatment prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer：A multicenter studyBao Li, Jie Tian, Zhenyu Liu et al.|The Breast|2022Cited by 45
Impact of the updated 2018 ASCO/CAP guidelines on HER2 FISH testing in invasive breast cancer: a retrospective study of HER2 fish results of 2233 casesZhihua Liu, Fangping Xu, Kun Wang et al.|Breast Cancer Research and Treatment|2019Cited by 44
HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS componentNing Liao, Yi‐Long Wu, Yan‐Hui Liu et al.|Pathology - Research and Practice|2010Cited by 43
Tau expression correlated with breast cancer sensitivity to taxanes-based neoadjuvant chemotherapyKun Wang, Yi‐Long Wu, Xuerui Li et al.|Tumor Biology|2012Cited by 40